Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Connie Ng Hess

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Hess, Connie

Item TypeName
Academic Article A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.
Academic Article Response by Hess and Hiatt to Letter Regarding Article, "A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative".
Academic Article Antithrombotic Therapy for Peripheral Artery Disease in 2018.
Academic Article Major Adverse Limb Events and 1-Year?Outcomes After Peripheral?Artery?Revascularization.
Concept Peripheral Arterial Disease
Academic Article Lost in translation: Why 'lost to follow-up' matters.
Academic Article Acute Limb Ischemia in Peripheral Artery Disease.
Academic Article Progress in the prevention and treatment of atherosclerotic cardiovascular disease: two steps forward, one step back.
Academic Article Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery Revascularization.
Academic Article Sex-Specific Risks of Major?Cardiovascular and Limb?Events?in?Patients With Symptomatic Peripheral Artery Disease.
Academic Article The Pathobiology of Acute Limb Ischemic?Events and Stent Failure in Peripheral Artery Disease: A Step in the Right Direction.
Academic Article Rivaroxaban in Peripheral Artery Disease after Revascularization.
Academic Article ASCVD Risk and Statin Use in PAD: Implementing a New Approach to an Old Problem.
Academic Article Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease.
Academic Article Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
Academic Article Long-term safety of drug-coated devices for peripheral revascularisation.
Academic Article Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization.
Academic Article Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization.
Academic Article Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD?Trial.
Academic Article Diabetes Mellitus and Risk Stratification After Peripheral Artery Revascularization.
Academic Article Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease.
Academic Article Ankle-Brachial Index for Risk Stratification in Patients With Symptomatic Peripheral Artery Disease With and Without Prior Lower Extremity Revascularization: Observations From the EUCLID Trial.
Academic Article Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial.
Academic Article Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
Academic Article Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association.
Academic Article Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD.
Academic Article Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery?Revascularization: Insights From VOYAGER PAD.
Academic Article Risk of remnants and remnant risk in peripheral artery disease.
Academic Article Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease.
Academic Article Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.
Academic Article Sex Differences in Peripheral Artery Disease.
Academic Article Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD.
Academic Article Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.
Academic Article Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD.
Academic Article Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
Academic Article Telmisartan and Walking Performance in Peripheral Artery Disease.
Academic Article Sex-Based Differences in Periprocedural Complications Following Lower Extremity Peripheral Vascular Intervention.
Academic Article Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
Academic Article Guideline-Directed Medical Therapy in?PAD: Time to Step on the Gas.
Academic Article Sex differences in guideline-directed medical therapy in 2021-22 among patients with peripheral artery disease.
Academic Article Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions.
Academic Article Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.

Search Criteria
  • Peripheral Arterial Disease

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)